Baker Brothers Advisors - Mast Therapeutics, Inc. ownership

Mast Therapeutics, Inc.'s ticker is and the CUSIP is 057631410. A total of 1 filers reported holding Mast Therapeutics, Inc. in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of Mast Therapeutics, Inc.
ValueSharesWeighting
Q2 2014$1,887,0003,000,0000.02%
Other shareholders
Mast Therapeutics, Inc. shareholders Q2 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 3,000,000$1,887,0000.02%
View complete list of Mast Therapeutics, Inc. shareholders